Cortex Pharmaceuticals (COR)
$0.15
-0.01 (-6.67%)
| CAPS Rating |
|
|---|---|
| Open | $0.16 |
| Previous Close | $0.15 |
| Daily Range | $0.15 - $0.16 |
| 52-Week Range | $0.14 - $0.81 |
| Market Cap | $10.26M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 32,300 |
| Average Daily Volume | 315,000 |
COR
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
COR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
COR News and Commentary
- Heads Up, Biotech Investors: Chapter 3 – The Motley Fool
- Consider Cortex – The Motley Fool
Related News and Articles
- 52-Week Highs! What's Going On? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- The Side Effect of Developing Obesity Drugs – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- Are These Dividends Too Good to Be True? – The Motley Fool
- This Baby Is a Nice Addition – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- 4-Star Stocks Poised to Pop: Merck – The Motley Fool
- Pfizer Dodges a Bullet – The Motley Fool
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- Why You Can't Afford to Miss These Stocks – The Motley Fool
- The Government Won't Be There for You – The Motley Fool
- Your Heart or Your Stomach? – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- VIVUS Gets a Spark – The Motley Fool
- Can This Stock Go Higher? – The Motley Fool
RSS Headlines
Fool UK
